There's a strong case that healthcare is the most important sector in the stock market. Investors stand to benefit as ...

The average Wall Street analyst following Editas Medicine ( EDIT 7.08%) thinks the gene therapy stock can reach $3.25 per ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

For World Sickle Cell Day, June 19, LSU Health announces its exhibition of new art on display at its Feist-Weiller Cancer Center, 1501 Kings Highway. An exhibition is going on display at LSU Health ...

Sixty-five children are at Camp Dreamcatcher, where kids battling serious conditions can swap medical appointments with camp activities.

Corresponding author Akshay Sharma, MBBS, MSc, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy talks ...

A legislative ban on pharma ads, a tool for companies to amplify messaging on drugs, including for precision medicines, is sure to face legal challenges, experts say.

Appeals court upholds Michigan's Newborn Screening Program's constitutionality, allowing continued early disease detection.

Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).

As practicing oncologists, we can get bogged down in our individual practices and thus have trouble seeing the bigger picture ...

The World Health Organization has released its first-ever global guideline on the management of sickle cell disease during ...

The Connecticut General Assembly's recently concluded session delivered some landmark victories combined with frustrating ...